Flu vaccine ordering for 2019/20


Flu vaccine ordering for 2019/20

November 20, 2018

Public Health England (PHE) has today (20th November 2018) issued a joint letter with NHS England and the Department of Health and Social Care to provide guidance to pharmacy contractors and general practices on ordering flu vaccines for the 2019/20 season.

This follows a review of the latest evidence on influenza vaccines conducted by the Joint Committee on Vaccination and Immunisation (JCVI), the body that advises UK health departments on immunisation, and the issuing of advice on the most effective vaccines for the 2019/20 flu season.

The joint letter advises that both of the vaccines that were recommended for the 2018/19 season (quadrivalent inactivated vaccine and adjuvanted trivalent inactivated vaccine) will continue to be recommended for next year. Both vaccines are currently licensed and available to order for use in the UK.

As in the 2018/19 season, standard trivalent vaccines (TIVe, previously known as TIV) are not to be used in any age or clinical at-risk group.

PHE also anticipates that two further products will be licensed within the ordering window for the 2019/20 flu season: a cell-based QIV, which will be suitable for use both in those aged 18 to 64 years and in those aged 65 years and over; and a high dose trivalent vaccine (TIV-HD) which will be suitable for those aged 65 years and over. Once licences are granted and list prices of the new vaccines have been agreed, NHS England will write to pharmacies and general practices confirming the full recommendations for the 2019/20 flu programme.

What should you do now?

Read the joint letter and begin ordering currently licensed vaccines as set out in the letter; ordering of these licensed vaccines should not be unnecessarily delayed.

For the new, currently unlicensed vaccines, please wait for confirmation from NHS England that they are eligible for reimbursement before ordering.


Posted in: ,

More Latest News >